immatics biotechnologies GmbH (4A3) — Financial Flexibility Index
immatics biotechnologies GmbH (4A3) has a Financial Flexibility Index of -0.69x as of June 2026. Free cash flow of €-59.59 Million (operating CF €-60.46 Million minus capex €871.00K) represents -1% of total liabilities (€86.11 Million). Check 4A3 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
immatics biotechnologies GmbH Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for immatics biotechnologies GmbH across 7 annual periods. For the full cash flow conversion analysis, see how efficiently does immatics biotechnologies GmbH generate cash.
Annual Financial Flexibility Index for immatics biotechnologies GmbH (2019–2025)
Year-by-year free cash flow to debt coverage for immatics biotechnologies GmbH. Explore 4A3 operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.17x | €-169.82 Million | €-176.63 Million | €78.24 Million | ▼ -86.0% |
| 2024 | -1.17x | €-141.55 Million | €-158.03 Million | €121.30 Million | ▼ -775.9% |
| 2023 | 0.17x | €49.19 Million | €18.23 Million | €284.88 Million | ▼ -68.3% |
| 2022 | 0.54x | €105.87 Million | €100.13 Million | €194.66 Million | ▼ -22.2% |
| 2021 | 0.70x | €105.24 Million | €100.13 Million | €150.58 Million | ▼ -2.3% |
| 2020 | 0.72x | €107.55 Million | €100.13 Million | €150.39 Million | ▲ +71.3% |
| 2019 | 0.42x | €73.11 Million | €70.97 Million | €175.11 Million | — |